lumivis bimatoprost 300 microgram/ml eye drops bottle
abbvie pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: hydrochloric acid; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; dibasic sodium phosphate heptahydrate; sodium chloride - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.
lumigan 300microgramsml eye drops
allergan ltd - bimatoprost - eye drops - 300microgram/1ml
ganfort 0.3mgml 5mgml eye drops
allergan ltd - bimatoprost; timolol maleate - eye drops - 300microgram/1ml ; 5mg/1ml
lumigan 100microgramsml eye drops
allergan ltd - bimatoprost - eye drops - 100microgram/1ml
lumigan 300microgramsml eye drops 0.4ml unit dose
allergan ltd - bimatoprost - eye drops - 300microgram/1ml
ganfort 0.3mgml 5mgml eye drops 0.4ml unit dose
allergan ltd - timolol maleate; bimatoprost - eye drops - 5mg/1ml ; 300microgram/1ml
sturiban 0.3mg/ml eye drops
actavis uk ltd - bimatoprost - eye drops - 300microgram/1ml
eyreida 0.3mg/ml eye drops
aspire pharma ltd - bimatoprost - eye drops - 300microgram/1ml
lumitoprost bimatoprost 300 microgram/ml eye drops bottle
arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections; hydrochloric acid; citric acid monohydrate; dibasic sodium phosphate heptahydrate; benzalkonium chloride - bimatoprost is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.
bimatigan bimatoprost 300 microgram/ml eye drops bottle
gm pharma international pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: hydrochloric acid; citric acid monohydrate; sodium chloride; benzalkonium chloride; sodium hydroxide; dibasic sodium phosphate heptahydrate; water for injections - bimatoprost is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.